Encompass Health Corporation
EHC
Peringkat dalam Saham
#1784
Encompass Health Corporation delivers a range of post-acute healthcare services... Encompass Health Corporation delivers a range of post-acute healthcare services across the United States, offered both in dedicated facilities and directly within patients' homes. The company's operations are divided into two primary divisions: Inpatient Rehabilitation, and Home Health and Hospice. Its Inpatient Rehabilitation division specializes in providing focused recovery treatment, available on an inpatient or outpatient basis. This care is designed for individuals recuperating from significant health challenges such as strokes, neurological disorders, cardiac and pulmonary issues, brain and spinal cord injuries, complex orthopedic conditions, and amputations. The Home Health and Hospice segment primarily serves the Southeast and Texas regions. Within this segment, home health services encompass a variety of Medicare-certified care options for adult patients, including skilled nursing, medical social work, home health aide assistance, and various therapies like physical, occupational, and speech therapy. Hospice services, on the other hand, provide in-home comfort and support for terminally ill patients and their families. As of June 1, 2022, Encompass Health maintained a substantial network, managing 149 hospitals, 252 home health locations, and 99 hospice locations spread across 42 U.S. states and Puerto Rico. The company, which established its roots in 1983 and is headquartered in Birmingham, Alabama, was formerly known as HealthSouth Corporation until its name change to Encompass Health Corporation in January 2018.
Harga Saham
$121.72
Terakhir disinkronkan: 2026-10-20
Kapitalisasi Pasar
$12.01B
Perubahan (1 hari)
-0.15%
Perubahan (1 tahun)
-2.55%
Negara
US
Perdagangan Encompass Health Corporation (EHC)
Kategori
Healthcare
Rasio P/E untuk Encompass Health Corporation (EHC)
Rasio P/E per October 2026 TTM: 20.35
Menurut laporan keuangan dan harga saham terbaru dari Encompass Health Corporation, rasio P/E saat ini (TTM) adalah 20.35. Pada akhir 2024, perusahaan memiliki rasio P/E sebesar 20.25.
Riwayat rasio P/E untuk Encompass Health Corporation dari 2000 hingga 2026
Rasio P/E di akhir setiap tahun
| Tahun | Rasio P/E | Mengubah |
|---|---|---|
| 2026 (TTM) | 20.35 | 8.00% |
| 2025 | 18.84 | -6.94% |
| 2024 | 20.25 | 7.35% |
| 2023 | 18.86 | -13.86% |
| 2022 | 21.89 | 75.67% |
| 2021 | 12.46 | -45.37% |
| 2020 | 22.81 | 51.59% |
| 2019 | 15.05 | -8.42% |
| 2018 | 16.43 | 14.40% |
| 2017 | 14.36 | 21.73% |
| 2016 | 11.80 | -12.69% |
| 2015 | 13.52 | 13.03% |
| 2014 | 11.96 | 65.79% |
| 2013 | 7.21 | -15.95% |
| 2012 | 8.58 | 36.61% |
| 2011 | 6.28 | 220.22% |
| 2010 | 1.96 | -85.96% |
| 2009 | 13.98 | 387.94% |
| 2008 | 2.86 | 42.39% |
| 2007 | 2.01 | -187.80% |
| 2006 | -2.29 | -33.86% |
| 2005 | -3.46 | -69.48% |
| 2004 | -11.35 | 241.03% |
| 2003 | -3.33 | -31.97% |
| 2002 | -4.89 | -121.51% |
| 2001 | 22.74 | 26.26% |
| 2000 | 18.01 | 0.00% |
Rasio P/E untuk perusahaan serupa atau pesaing
| Perusahaan | Rasio P/E | Perbedaan Rasio P/E | Negara |
|---|---|---|---|
| 15.70 | -22.83% |
US
|
|
| - | - |
DE
|
|
| 10.40 | -48.90% |
US
|
|
| 32.07 | 57.61% |
SA
|
|
| 20.00 | -1.71% |
BR
|
Bagaimana cara membaca P/E ratio?
Rasio Harga/Laba (P/E) mengukur hubungan antara harga saham perusahaan dan laba per sahamnya.
P/E yang rendah namun positif menunjukkan perusahaan dengan laba tinggi dibandingkan valuasinya saat ini dan mungkin dianggap undervalued. P/E negatif tinggi (mendekati 0) menunjukkan perusahaan yang mengalami kerugian besar.
Perusahaan dengan P/E di atas 30 atau negatif umumnya dianggap sebagai "saham pertumbuhan", artinya investor mengharapkan pertumbuhan atau keuntungan di masa depan.
Perusahaan dengan P/E positif di bawah 10 dianggap sebagai "saham bernilai", artinya perusahaan sudah sangat menguntungkan dan pertumbuhannya kemungkinan tidak besar.